Partner With Us NRI

Strides Pharma Science Ltd share Price Today

Company details

6M Return 30.80%
1Y Return 46.51%
Mkt Cap.(Cr) 4,467.42
Volume 83,849
Div Yield 0.30%
OI Chg %
Volume 83,849

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Pharmaceuticals company Strides Pharma Science announced Q1FY24 results:

  • Reports quarterly sales of Rs 9,320 million in Q1FY24, down 1% YoY
  • Q1FY24 gross margins at 58.7%, absolute gross margin increase of Rs 729 million YoY
  • Consolidated EBITDA at Rs 1,686 million, up 100% YoY with healthy EBITDA margin expansion
  • Significant optimization of operating costs resulted in improved operating leverage
  • Key businesses deliver steady performance, and cost control measures yielding results
  • Levers in place to deliver a strong performance in FY24 with improved profitability and a stronger balance sheet

Arun Kumar, Founder, Managing Director, and Executive Chairperson, commented on the performance and said, “We are pleased to report a strong start to FY24, with Q1FY24 EBITDA reaching historical highs. Our focus on profitability and efficiency is witnessed in the results as we expanded EBITDA margins by 200 bps QoQ and generated strong operating cash flows. We are on track to achieve the targets we set out for FY24 at the beginning of this year on all financial parameters.

The Regulated markets grew by 25% YoY with the US growing by 32% YoY and Other Regulated markets growing by 15% YoY. The growth is driven by a disciplined approach to product launches and sustainable market share on existing products. The emerging markets' performance had a slow start and is expected to gain traction during the year.

We are confident of sustaining the momentum in performance driven by continuous improvement in the quality of business and delivering a strong cash generation going forward.”



Result PDF

View Other Company Results


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Strides Pharma Science Ltd Stocks COMPARISION


Equity Capital: 2,195.16 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 12,712.30 1,203.68
LAST 3M 53,432.71 -18,778.89
LAST 6M 89,253.22 63,124.76
LAST 12M 155,874.96 111,270.77
Strides Pharma Science Limited - Loss of Share Certificates

Nov 28, 2023 l NSE Announcement

Strides Pharma Science Limited - Press Release

Nov 23, 2023 l NSE Announcement

Strides Pharma Global receives USFDA approval for generic Suprep® Bowel Prep Kit

Nov 23, 2023 l BSE Announcement

Date Action Type Ratio
Aug 04, 2023 Dividend 15
Aug 05, 2021 Dividend 25

Strides Pharma Science Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
Registered Address

No 201 Devavrata Sector 17, Vashi, Navi Mumbai, Maharashtra, 400703

Tel : 91-22-27892924/27893199
Email : investors:stridesshasun.com
Website : http://www.stridesarco.com

Karvy Computershare Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 532531
Book Closure Date (Month) :
BSE Group : A
ISIN : INE939A01011

FAQ’s on Strides Pharma Science Ltd Shares

You can buy Strides Pharma Science Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Strides Pharma Science Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Nov 29, 2023 10:59 AM the closing price of Strides Pharma Science Ltd was ₹ 494.55.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Nov 29, 2023 10:59 AM, the market cap of Strides Pharma Science Ltd stood at ₹ 4,467.42.

The latest PE ratio of Strides Pharma Science Ltd as of Nov 29, 2023 10:59 AM is 0

The latest PB ratio of Strides Pharma Science Ltd as of Nov 29, 2023 10:59 AM is 0.45

The 52-week high of Strides Pharma Science Ltd is ₹ 549.00 while the 52-week low is ₹ 268.15

Download Our App

market app
market app